EUVIMEDEUVIMED entdecken
Validierungsstudie

A validated method for capillary phosphatidylethanol 16:0/18:1 quantification with two different 10-µl volumetric absorptive microsample devices in the same setup

Trine N Andreassen iD, Marina Gule, Hilde Havnen, Olav Spigset, Ragnhild Bergene Skråstad

Journal of Analytical Toxicology · 2025

DOI: 10.1093/jat/bkaf004 ↗

Kurz gefasst

Validierungsstudie in der Zeitschrift Journal of Analytical Toxicology, 2025. Verfasst von Trine N Andreassen und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical Pharmacology, St. Olavs University Hospital, Trondheim 7006, Norway. Hauptthemen laut MEDLINE: Glycerophospholipids, Dried Blood Spot Testing. Die Arbeit nennt 57 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

There is a growing interest for quantification of drugs in capillary blood. Phosphatidylethanol (PEth) is a biomarker for alcohol intake measured in whole blood, thus making it a candidate for capillary sampling. Our laboratory has been running a method for PEth quantification in venous blood since 2016, and we aimed to expand this method to also include capillary dried blood spot (DBS) samples. Two 10-µl volumetric absorptive microsampling (VAMS) devices, Capitainer®B Vanadate and Mitra®, were included in the method development and validated. Calibrators and quality controls were spiked during automatic sample extraction without the VAMS devices present, making it possible to extract and analyze both types of VAMS samples in the same setup. With the Mitra device, all pre-established validation criteria were fulfilled in the measuring range of 0.03 to 4.0 µM (21–2812 ng/mL), including method comparison with our venous blood method. Capitainer fulfilled all validation criteria, except for the accuracy of samples with PEth levels ≥ 0.5 µM (≥ 352 ng/mL) (deviation −17.1% to −20.5%). The correlation analysis between Capitainer and the venous blood results showed no constant bias, but an acceptable small proportional mean difference of −7.6%. Overall, the method validation results for both Capitainer and Mitra were considered acceptable. Both devices were found to be suitable for the analyses of PEth.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

GlycerophospholipidsDried Blood Spot TestingHumansReproducibility of ResultsBlood Specimen CollectionBiomarkersCalibrationLimit of Detection

Substanzen

GlycerophospholipidsphosphatidylethanolBiomarkers

Autor:innen und Institutionen

  • Department of Clinical Pharmacology, St. Olavs University Hospital, Trondheim 7006, Norway.
  • Department of Clinical and Molecular Medicine, Norwegian University of Science and Technology, Trondheim 7030, Norway.

ORCID-Profile: Trine N Andreassen

Zitieren

APA

Andreassen, T. N., Gule, M., Havnen, H., Spigset, O., & Skråstad, R. B. (2025). A validated method for capillary phosphatidylethanol 16:0/18:1 quantification with two different 10-µl volumetric absorptive microsample devices in the same setup. Journal of Analytical Toxicology. https://doi.org/10.1093/jat/bkaf004

Vancouver

Andreassen TN, Gule M, Havnen H, Spigset O, Skråstad RB. A validated method for capillary phosphatidylethanol 16:0/18:1 quantification with two different 10-µl volumetric absorptive microsample devices in the same setup. Journal of Analytical Toxicology. 2025. doi:10.1093/jat/bkaf004

BibTeX
@article{Andreassen2025,
  author = {Andreassen, Trine N and Gule, Marina and Havnen, Hilde and Spigset, Olav and Skråstad, Ragnhild Bergene},
  title = {A validated method for capillary phosphatidylethanol 16:0/18:1 quantification with two different 10-µl volumetric absorptive microsample devices in the same setup},
  journal = {Journal of Analytical Toxicology},
  year = {2025},
  doi = {10.1093/jat/bkaf004}
}
Kostenlos starten →